Menu Back toSESSION-5-SAFETY-REPORTING

Clinical Trial Regulation Conference

This conference provides a forum for information exchange and discussion on conceptual and practical questions about critical issues affecting sponsors and Member States regarding the implemention the regulation.


SESSION 5: SAFETY REPORTING IN THE EU CLINICAL TRIAL REGULATION- AN UPDATE ON DEVELOPMENTS AND INTERACTIVE Q&A SESSION

Session Chair(s)

Esteban  Herrero-Martinez, DrSc, PhD

Esteban Herrero-Martinez, DrSc, PhD

  • Director Regulatory Policy and Intelligence
  • Abbvie Ltd, United Kingdom

Interactive question and answer session between industry and regulators (CTFG rep and EMA rep) to discuss recent developments, outstanding issues and current thinking on clinical trial safety reporting

Speaker(s)

Elke  Stahl, PhD

Elke Stahl, PhD

  • CTFG Co-Chair; Clinical Trial Unit
  • Federal Institute For Drugs and Medical Devices (BfArM), Germany
Amanda  Joseph

Amanda Joseph

  • EU Advisor, Clinical Case Management
  • Eli Lilly and Company, United Kingdom
Camelia  Mihaescu

Camelia Mihaescu

  • GCP, GLP and PhV Inspections
  • European Medicines Agency, Netherlands

Contact us

 Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics Questions

Send Email
+41 61 225 51 49